In this study, we found both higher median percentage of PB CD4+ T-cells with intracellular expression of IL-17A and higher IL-17A plasma level in patients with CLL comparing to the healthy control that might suggest the potential role of IL-17 and Th17 cells in CLL immunobiology. This evidence concerns the gene IL17A and B-cell chronic lymphocytic leukemia.